Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

DePuy Hip Replacement Recall

Posted in DePuy Hip Replacement

Some types of medical products have to go through a special FDA approval process before they can be sold.  The manufacturers of those products are immune from suit due to a questionable Supreme Court decision.  Thankfully, the DePuy hip replacement components are not covered by that Supreme Court decision and individuals injured by those components can find a lawyer to help them:

DePuy Orthopaedics Inc., Warsaw, U.S.A., has voluntarily recalled two of its ASR hip replacement components — the ASR XL Acetabular System and the ASR Hip Resurfacing System — due to the rates of revision surgery with them.

New, unpublished data from the National Joint Registry of England and Wales (NJR) show a 5-year revision rate of approximately 12% for the ASR Hip Resurfacing System and approximately 13% for the ASR XL Acetabular System. Those revision rates included all ranges of component sizes, but the revision risk was highest with ASR head sizes less than 50 mm in diameter and among women, according to an August 26 press release from DePuy Orthopaedics.

Source: DePuy recalls ASR Hip System due to revision rates

I haven’t done much investigation into the DePuy hip replacement recall, but if you think you have one, contact me and I’ll see what I can find out for you.